EFFICACY OF CLARITHROMYCIN AGAINST MYCOPLASMA-PNEUMONIAE

被引：59

作者：

CASSELL, GH

DRNEC, J

WAITES, KB

PATE, MS

DUFFY, LB

WATSON, HL

MCINTOSH, JC

机构：

[1] ABBOTT LABS, ABBOTT PK, IL 60064 USA

[2] UNIV ALABAMA, DEPT PATHOL, BIRMINGHAM, AL 35294 USA

[3] UNIV ALABAMA, DEPT PEDIAT, BIRMINGHAM, AL 35294 USA

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 1991年 / 27卷

关键词：

D O I：

10.1093/jac/27.suppl_A.47

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：47 / 59

页数：13

共 23 条

[1]

CASSELL GH, 1988, REV INFECT DIS, V10, pS391

[2] MYCOPLASMAS AS AGENTS OF HUMAN-DISEASE [J].

CASSELL, GH ;

COLE, BC .

NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (02) :80-89

[3] COMPARATIVE SUSCEPTIBILITY OF MYCOPLASMA-PNEUMONIAE TO ERYTHROMYCIN, CIPROFLOXACIN, AND LOMEFLOXACIN [J].

CASSELL, GH ;

WAITES, KB ;

PATE, MS ;

CANUPP, KC ;

DUFFY, LB .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1989, 12 (05) :433-435

[4]

Cassell GH., 1985, MYCOPLASMAS MYCOPLAS, V4, P65, DOI [10.1016/B978-0-12-078404-2.50010-5, DOI 10.1016/B978-0-12-078404-2.50010-5]

[5]

CHOW AW, 1984, ANTIMICROBIAL THERAP

[6]

Fernandes P. B., 1987, Antimicrobic Newsletter, V4, P25, DOI 10.1016/0738-1751(87)90002-5

[7] INVITRO AND INVIVO EVALUATION OF A-56268 (TE-031), A NEW MACROLIDE [J].

FERNANDES, PB ;

BAILER, R ;

SWANSON, R ;

HANSON, CW ;

MCDONALD, E ;

RAMER, N ;

HARDY, D ;

SHIPKOWITZ, N ;

BOWER, RR ;

GADE, E .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (06) :865-873

[8]

FURNERI PM, 1987, CHEMIOTERAPIA, V6, P346

[9]

FURNERI PM, 1987, CHEMIOTERAPIA, V6, P341

[10] LABORATORY DIAGNOSIS OF MYCOPLASMA-PNEUMONIAE INFECTION .3. DETECTION OF IGM ANTIBODIES TO M-PNEUMONIAE BY A MODIFIED INDIRECT HEMAGGLUTINATION TEST [J].

KOK, TW ;

MARMION, BP ;

VARKANIS, G ;

WORSWICK, DA ;

MARTIN, J .

EPIDEMIOLOGY AND INFECTION, 1989, 103 (03) :613-623

← 1 2 3 →